In March 2025, the company introduced new plans for the direct-to-customer supplying of its Wegovy weight loss drug. The company founded a completely new pharmacy, called NovoCare, which might demand customers $499 per 30 days for use of the drug, lower than half the cost of the drug via other pharmaceutical distribution networks.[fifty three]are s